期刊文献+

脂肪因子Omentin-1通过磷脂酰肌醇-3激酶/蛋白激酶B通路抑制泡沫巨噬细胞炎症因子释放及凋亡的研究 被引量:7

Adipokine omentin-1 inhibits inflammatory cytokines secretion and apoptosis in macrophage
下载PDF
导出
摘要 目的:探讨脂肪因子Omentin-1对泡沫巨噬细胞炎症因子的释放以及凋亡的影响及机制。方法:THP-1细胞系用佛波酯(PMA)诱导为巨噬细胞后,加入氧化低密度脂蛋白(ox-LDL)构建泡沫巨噬细胞模型。采用不同浓度Omentin-1孵育泡沫巨噬细胞48 h后,利用Westernblot技术测定细胞中凋亡相关蛋白bcl-2、bax、caspase-3表达情况,并利用Annexin V试剂盒测定细胞凋亡率。在泡沫巨噬细胞中加入Omentin-1以及PI3K/AKT通路阻断剂LY294002,利用RT-qPCR技术及ELISA试剂盒测定细胞内及培养液中炎症因子TNF-α与IL-6的表达与分泌情况。在巨噬细胞中加入Omentin-1,分别于加入后不同时间点提取蛋白,之后采用LY294002抑制磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)通路,并用Westernblot技术测定细胞中蛋白激酶B以及Ser473位点磷酸化蛋白激酶B的表达量。结果:与对照组相比,加入Omentin-1后泡沫巨噬细胞凋亡率显著下降(P<0.05),细胞caspase-3、bax蛋白表达显著下降,bcl-2蛋白表达显著上升(P<0.01),抑制PI3K/AKT通路后,以上效应均显著减弱(P<0.05)。与对照组相比,加入Omentin-1可显著抑制泡沫巨噬细胞炎症因子释放(P<0.05),抑制PI3K/AKT通路后,此效应显著减弱(P<0.05)。与对照组相比,加入Omentin-1后细胞内Ser473位点磷酸化蛋白激酶B/蛋白激酶B比值显著上升(P<0.01)。油红O染色提示Omentin-1可显著减少ox-LDL诱导的泡沫细胞内的脂质含量(P<0.05),抑制PI3K/AKT通路后此效应未受显著影响(P>0.05)。结论:Omentin-1可能通过磷脂酰肌醇-3激酶/蛋白激酶B通路调控泡沫巨噬细胞炎症因子释放与凋亡。 Objective: To investigate how Omentin-1 regulate macrophage-derived foam cell pro-inflammatory cytokine secretion and apoptosis. Methods: We utilized PMA at concentration of 100 ng/mL to induce THP-1 monocytes into macrophages. After 48 hours of incubation, we added 50μg/mL ox-LDL and prolonged the incubation time to another 48 hours in order to establish macrophage-derived foam cell in vitro. THP-1-derived macrophages were treated with Omentin-1 at 800 ng/mL, and the protein was extracted at 15 min, 30 min, and 60 min, respectively. LY294002 was used to block PI3K/AKT signaling pathway, and Western Blot was used to determine the expression levels of AKT and phospho-AKT(ser473) in cells. The cells were also divided into macrophage group, foam cell group, foam cell group with addition of Omentin-1 and foam cell group with addition of Ometin-1 and LY294002. RT-qPCR and ELISA was used to measure the mRNA levels and cytokine secretion levels of TNF-α and IL-6 in each group. After incubation with Omentin-1 at different concentrations for 48 h, foam cells were subjected to Western Blot analysis in order to measure the expression levels of bcl-2, bax and caspase-3. The ratio of apoptotic cells was determined by Annexin V assay kit. Results: Compared with the control group, Omentin-1 ameliorated the expression of apoptosis-related proteins caspase-3(P<0.01) in macrophages through the PI3K/AKT pathway, and inhibited the apoptosis of macrophages(P<0.05). In macrophages induced by ox-LDL and LPS, Omentin-1 inhibited the expression and release of inflammatory cytokines via PI3K/AKT pathway(P<0.05). An increase of expression of phospho-AKT(Ser473) was observed after addition of Omentin-1(P<0.01). Oil red staining revealed that Omentin-1 significantly reduced the content of lipid droplets in macrophages treated with ox-LDL(P<0.05). Conclusions: Omentin-1 inhibits foam cell inflammatory cytokine release and apoptosis via PI3K/AKT pathway.
作者 林徐泽 王志坚 周玉杰 LIN Xuze;WANG Zhijian;ZHOU Yujie(Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart Lung and Blood Vessel Disease,Beijing 100029,China)
出处 《心肺血管病杂志》 2019年第9期975-981,共7页 Journal of Cardiovascular and Pulmonary Diseases
基金 国家自然科学基金面上项目资助(81670391)
关键词 动脉粥样硬化 脂肪因子Omentin-1 PI3K/AKT通路 巨噬细胞 细胞实验 Atherosclerosis Adiplkine Omemtin-1 PI3K/AKT pathway Machrophage Cell experiment
  • 相关文献

参考文献1

二级参考文献24

  • 1Alsheikh-Ali AA,Kitsios GD,Balk EM,et al.The vulnerable atherosclerotic plaque:scope of the literature.Ann Intern Med,2010,153:387-395.
  • 2Schelbert EB,Cao JJ,Sigurdsson S,et al.Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.JAMA,2012,308:890-896.
  • 3Goff DC Jr,Lloyd-Jones DM,Bennett G,et al.2013 ACC/AHA Guideline on the assessment of cardiov ascular risk:A report of the american college of cardiology/american heart association task force on practice guidelines.Circulation,2013[Epub ahead of print].
  • 4Anderson TJ,Grégoire J,Hegele RA,et al.2012 Update of the canadian cardiov ascular society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiov ascular dise ase in the adult.Can J Cardiol,2013,29:151-167.
  • 5European association for cardiov Ascular prevention&rehabilitation(EACPR);ESC committee for practice guidelines(CPG).European guidelines on cardiov Ascular dise Ase prevention in clinical practice(version 2012).The fifth joint task force of the european society of cardiology and other societies on cardiov Ascular dise ase prevention in clinical practice(constituted by representatives of nine societies and by invited experts).Eur Heart J,2012,33:1635-1701.
  • 6中华医学会心血管病分会,中华心血管病杂志编委会.中国心血管病预防指南.中华心血管病杂志,2011,39:3-22.
  • 7The emerging risk factors collaboration.Lipid-related markers and cardiov ascular dise ase prediction.JAMA,2012,307:2499-2506.
  • 8David SW.Current Progress in computational metabolomics.Brief Bioinform,2007,8:279-293.
  • 9Barder As MG,Laborde CM,Posada M,et al.Metabolomic profiling for identification of novel potential biomarkers in cardiov Ascular dise Ases.J Biomed Biotechnol,2011,2011:7901-7932.
  • 10Monteiro MS,Carvalho M,BAstos ML,et al.Metabolomics analysis for biomarker discovery:advances and challenges.Curr Med Chem,2013,20:257-271.

共引文献8

同被引文献54

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部